Research ArticleClinical Studies
Factors Associated with the Selection of First-line Bevacizumab plus Chemotherapy and Clinical Response in HER2-negative Metastatic Breast Cancer: ONCOSUR AVALOX Study
LUÍS MANSO, ANDRÉS GARCÍA PALOMO, RAMÓN PÉREZ CARRIÓN, JAVIER CASSINELLO, ISABEL GALLEGOS SANCHO, IGNACIO CHACÓN LÓPEZ-MUÑIZ, CLARA OLIER, ANTONIO FERNÁNDEZ-ARAMBURO, CRISTINA LLORCA, XAVIER GONZÁLEZ, ROSA LLORENTE, DOLORES TORREGROSA, IÑAKI ÁLVAREZ, ELENA GÁLVE, CORALIA BUENO, ISABEL GARAU, MARÍA JOSÉ GARCÍA, SANTIAGO GONZÁLEZ-SANTIAGO, ANA ISABEL BALLESTEROS, ESPERANZA BLANCO, ANTONIO GALÁN, SONIA GONZÁLEZ, ANTONIA PERELLÓ, HERNÁN CORTÉS-FUNES and CRISTINA GRÁVALOS
Anticancer Research December 2015, 35 (12) 6941-6950;
LUÍS MANSO
1Hospital 12 de Octubre, ONCOSUR, Madrid, Spain
ANDRÉS GARCÍA PALOMO
2Hospital de León, León, Spain
RAMÓN PÉREZ CARRIÓN
3Clínica Quirón Madrid, Madrid, Spain
JAVIER CASSINELLO
4Hospital de Guadalajara, ONCOSUR, Guadalajara, Spain
ISABEL GALLEGOS SANCHO
5Hospital General de Segovia, ONCOSUR, Segovia, Spain
IGNACIO CHACÓN LÓPEZ-MUÑIZ
6Hospital Virgen de la Salud, ONCOSUR, Toledo, Spain
CLARA OLIER
7Hospital de Alcorcón, ONCOSUR, Madrid, Spain
ANTONIO FERNÁNDEZ-ARAMBURO
8Complejo Hospitalario Universitario de Albacete, Albacete, Spain
CRISTINA LLORCA
9Hospital de Elda, Alicante, Spain
XAVIER GONZÁLEZ
10Hospital Clinic i Provincial, Barcelona, Spain
ROSA LLORENTE
11Hospital Dr. Peset, Valencia, Spain
DOLORES TORREGROSA
12Hospital de Luis Alcanyis, Xátiva, Valencia, Spain
IÑAKI ÁLVAREZ
13Hospital General San Jorge, Huesca, Spain
ELENA GÁLVE
14Hospital de Basurto, Vizcaya, Spain
CORALIA BUENO
15Hospital Infanta Cristina, ONCOSUR, Madrid, Spain
ISABEL GARAU
16Hospital Son Llatzer, Palma de Mallorca, Spain
MARÍA JOSÉ GARCÍA
17Hospital General de Ciudad Real, ONCOSUR, Ciudad Real, Spain
SANTIAGO GONZÁLEZ-SANTIAGO
18Hospital San Pedro de Alcántara, ONCOSUR, Cáceres, Spain
ANA ISABEL BALLESTEROS
19Hospital Universitario La Princesa, Madrid, Spain
ESPERANZA BLANCO
20Hospital Infanta Cristina, ONCOSUR, Badajoz, Spain
ANTONIO GALÁN
21Hospital de Sagunto, Valencia, Spain
SONIA GONZÁLEZ
22Hospital Mutua de Terrassa, Barcelona, Spain
ANTONIA PERELLÓ
23Hospital Son Dureta, Palma de Mallorca, Spain
HERNÁN CORTÉS-FUNES
1Hospital 12 de Octubre, ONCOSUR, Madrid, Spain
CRISTINA GRÁVALOS
1Hospital 12 de Octubre, ONCOSUR, Madrid, Spain
In this issue
Anticancer Research
Vol. 35, Issue 12
December 2015
Factors Associated with the Selection of First-line Bevacizumab plus Chemotherapy and Clinical Response in HER2-negative Metastatic Breast Cancer: ONCOSUR AVALOX Study
LUÍS MANSO, ANDRÉS GARCÍA PALOMO, RAMÓN PÉREZ CARRIÓN, JAVIER CASSINELLO, ISABEL GALLEGOS SANCHO, IGNACIO CHACÓN LÓPEZ-MUÑIZ, CLARA OLIER, ANTONIO FERNÁNDEZ-ARAMBURO, CRISTINA LLORCA, XAVIER GONZÁLEZ, ROSA LLORENTE, DOLORES TORREGROSA, IÑAKI ÁLVAREZ, ELENA GÁLVE, CORALIA BUENO, ISABEL GARAU, MARÍA JOSÉ GARCÍA, SANTIAGO GONZÁLEZ-SANTIAGO, ANA ISABEL BALLESTEROS, ESPERANZA BLANCO, ANTONIO GALÁN, SONIA GONZÁLEZ, ANTONIA PERELLÓ, HERNÁN CORTÉS-FUNES, CRISTINA GRÁVALOS
Anticancer Research Dec 2015, 35 (12) 6941-6950;
Factors Associated with the Selection of First-line Bevacizumab plus Chemotherapy and Clinical Response in HER2-negative Metastatic Breast Cancer: ONCOSUR AVALOX Study
LUÍS MANSO, ANDRÉS GARCÍA PALOMO, RAMÓN PÉREZ CARRIÓN, JAVIER CASSINELLO, ISABEL GALLEGOS SANCHO, IGNACIO CHACÓN LÓPEZ-MUÑIZ, CLARA OLIER, ANTONIO FERNÁNDEZ-ARAMBURO, CRISTINA LLORCA, XAVIER GONZÁLEZ, ROSA LLORENTE, DOLORES TORREGROSA, IÑAKI ÁLVAREZ, ELENA GÁLVE, CORALIA BUENO, ISABEL GARAU, MARÍA JOSÉ GARCÍA, SANTIAGO GONZÁLEZ-SANTIAGO, ANA ISABEL BALLESTEROS, ESPERANZA BLANCO, ANTONIO GALÁN, SONIA GONZÁLEZ, ANTONIA PERELLÓ, HERNÁN CORTÉS-FUNES, CRISTINA GRÁVALOS
Anticancer Research Dec 2015, 35 (12) 6941-6950;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.